Patients with TSH-secreting adenomas have lower bone mineral density than euthyroid individuals, but surgery lowers levels of ...

While the liver is the body’s main detoxifying organ, working around the clock to filter toxins from the blood, metabolize ...

Dr. Paul Kalliokoski told Newsweek that routine screening in early pregnancy for women in risk groups would be "a prudent ...

CNW/ - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Health Canada has approved LYVDELZI (seladelpar) for the ...

Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...

ORLANDO -- A non-hormonal treatment for menopausal moderate-to-severe vasomotor symptoms that just nabbed FDA approval was ...

Health Canada has granted conditional approval for Gilead Sciences’ Lyvdelzi for PBC patients who have difficulty with ...

Theriva™ Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing ...

A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...

In medicine, treatment goals set by physicians might differ from patient priorities. Although normalisation of laboratory parameters is a target supported by outcomes data, patient perspectives ...

Theriva Biologics (NYSE American: TOVX), ("Theriva" or the "Company"), a diversified clinical-stage company developing therapeutics designed to treat ...

Xie of Wanhuida Intellectual Property analyses how China’s patent authorities and courts assess second medical use inventions ...